Original language | English (US) |
---|---|
Pages (from-to) | 1525-1528 |
Number of pages | 4 |
Journal | Leukemia |
Volume | 24 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2010 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Leukemia, Vol. 24, No. 8, 08.2010, p. 1525-1528.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Clonal chromosomal abnormalities in CD34+/CD-38 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
AU - Bumm, T.
AU - Deininger, J.
AU - Newell, A. H.
AU - Lawce, H.
AU - Olson, S.
AU - Mauro, M.
AU - Druker, B.
AU - Deininger, M.
N1 - Funding Information: Oregon Health & Science University and BD have a financial interest in MolecularMD. The technology used in this research has been licensed to MolecularMD. This potential conflict of interest has been reviewed and managed by the Oregon Health & Science University Conflict of Interest in Research Committee and the Integrity Program Oversight Council. Oregon Health & Science University has clinical trial contracts with Novartis and Bristol-Myers Squibb to pay for patient costs, nurse and data manager salaries, and institutional overhead. BD does not derive salary nor does his laboratory receive funds from these contracts. MD is a consultant for Novartis and Bristol-Myers Squibb and was supported by Genzyme and Cytopia. The remaining authors declare no competing financial interests. Funding Information: We thank Jonathan VanDycke for help with FACS analysis. This work was supported in part by the NHLBI Grant HL082978-01 (MD), the Leukemia and Lymphoma Society 7393–06: Specialized Center of Research (MD). Michael Deininger is a Scholar in Clinical Research of the Leukemia & Lymphoma Society.
PY - 2010/8
Y1 - 2010/8
UR - http://www.scopus.com/inward/record.url?scp=77955709776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955709776&partnerID=8YFLogxK
U2 - 10.1038/leu.2010.123
DO - 10.1038/leu.2010.123
M3 - Letter
C2 - 20535153
AN - SCOPUS:77955709776
SN - 0887-6924
VL - 24
SP - 1525
EP - 1528
JO - Leukemia
JF - Leukemia
IS - 8
ER -